This review focuses on the role of PRL and hyperprolactinemia on important CVD risk factors such as systemic arterial hypertension, dyslipidemia, atherosclerosis, endothelial dysfunction, glucose metabolism, and body weight. This evidence concerns the gene PRL and endothelial dysfunction.